argenx to Present at 41st Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

Amsterdam, January 3, 2023 – argenx (ARGX), a global immunology company focused on severe autoimmune diseases, will have its CEO, Tim Van Hauwermeiren, present at the 41st Annual J.P. Morgan Healthcare Conference on January 9, 2023, at 9:00 a.m. PT. A live webcast of the presentation will be available on the argenx investors page. A replay will be accessible for 30 days post-event.

January 3, 2023

Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that Tim Van Hauwermeiren, Chief Executive Officer, will present at the 41^st Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2023 at 9:00 a.m. PT.

A live webcast of the presentation may be accessed on the Investors section of the argenx website at argenx.com/investors. A replay of the webcast will be available on the argenx website for approximately 30 days following the presentation.

About argenx
argenx is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases. Partnering with leading academic researchers through its Immunology Innovation Program (IIP), argenx aims to translate immunology breakthroughs into a world-class portfolio of novel antibody-based medicines. argenx developed and is commercializing the first-and-only approved neonatal Fc receptor (FcRn) blocker in the U.S., Japan and the EU. The Company is evaluating efgartigimod in multiple serious autoimmune diseases and advancing several earlier stage experimental medicines within its therapeutic franchises. For more information, visit www.argenx.com and follow us on LinkedIn, Twitter, and Instagram.

For further information, please contact:

Media:

Kelsey Kirk
kkirk@argenx.com

Investors:

Beth DelGiacco
bdelgiacco@argenx.com

FAQ

When is argenx presenting at the J.P. Morgan Healthcare Conference?

argenx will present on January 9, 2023, at 9:00 a.m. PT.

Who is presenting for argenx at the conference?

Tim Van Hauwermeiren, the CEO of argenx, will present.

How can I watch the argenx presentation live?

The live webcast will be accessible on the argenx investors website.

Will there be a replay of the argenx presentation?

Yes, a replay will be available for approximately 30 days after the event.

What is the focus of argenx as a company?

argenx focuses on developing innovative therapies for severe autoimmune diseases.